Discover Our Group:

Berlin-Chemie has been developing, manufacturing and distributing pharmaceutical products for over 130 years and has been a wholly owned subsidiary of the Menarini Group, the leading Italian pharmaceutical company, since 1992. 

Responsibility is a top priority at Berlin-Chemie. We not only make an important contribution to healthcare, but also put our values into practice through various social initiatives.

Discover More about Global Responsibility

From school kits to free meals and medicines, to caring for the environment around the world. In Menarini, being responsible means translating our values into concrete actions that are good for others and good for the planet

Berlin-Chemie – a strong partner. Our many years of experience and the success of joint projects make us the partner of choice. 

Discover More about Global Partnering

Menarini has in-depth know-how in many important therapeutic areas, thanks to many years of excellent market introduction, marketing and sales capabilities as well as expertise in regulatory aspects and market access. Collaboration is the key to great success, and at Menarini, partnership is part of the DNA.

Our holistic and professional health management offers doctors individual counselling, training or workshops, events and lectures on many topics, depending on their needs.

Our Medical Hub acts as a central point of contact for doctors and healthcare professionals. Here you will find all the information about our medications, additional service and training opportunities.

Welcome to the News & More section. Here you will find general information in the form of press releases, news and the latest graphical material. 

Menarini Blog

Follow Us

We employ professionals with a wide variety of career backgrounds and are employers who care about their staff. Together, we stand for innovation and reliability.

Our Job Portal

Find out about our current vacancies at Berlin-Chemie directly on our career portal.

Menarini Group News

2010 - 02 - 02

Malesci Congresses with "Zero Impact®" on the environment

The Malesci Pharmaceutical company, member of the Menarini Group, has enrolled in the innovative Lifegate Zero Impact® project, sponsoring scientific congresses organised with the environment in mind.

Zero Impact® is the first project in Italy to put into action the concepts laid down in the Kyoto protocol aimed at reducing the emissions of carbon dioxide and compensating any damage by planting trees to create new forests.

Even at the 2 nd International Cardio Event on Innovations in the field of Cardiology from a Clinical, Epidemiological and Methodological viewpoint, held last January and sponsored by Malesci in co-operation with LifeGate, the environmental impact in terms of CO 2 emissions generated by the event was assessed. Taking into account the amount of electricity used, the emissions generated by participants’ cars, as well as all other emissions of CO 2 and gases with a potential ‘greenhouse’ effect, LifeGate was able to calculate the number of square metres of trees and plants necessary to compensate for the total amount of emissions generated (hence rendering the event Zero Impact®!)

"The idea of compensating the ecological footprint left by the events we hold is the result of an assiduous focus on socio-environmental issues. Our commitment over the past two years has given us the opportunity to plant more than 25.000 square metres of forest in Costa Rica, one of the world’s greatest areas of biodiversity, and to reabsorb approximately 70.000 kgs of CO 2 . By doing this we are not only fulfilling our ethical and social obligations but also going beyond the limits established by the laws in force ", commented Dr. Bertolaccini, General Manager of Malesci.

Firenze, 02/02/2010